Molina Healthcare, Inc. (NYSE: MOH) shares are under pressure after the company and its industry peers issued multiple profit warnings and cut earnings guidance, citing surging medical costs. Investors are weighing a recent rebound in the stock against ongoing headwinds from Medicaid, Medicare and Affordable Care Act (ACA) plan expenses.
Positive Sentiment:
Despite trimming its profit outlook, Molina’s shares have climbed recently as investors view last week’s selloff as overdone.
Another health insurer has issued a profit warning. But its stock is climbing.
Neutral Sentiment:
Analysts at Zacks are evaluating whether MOH is undervalued after the correction, focusing on earnings estimate revisions and valuation metrics.
Is Molina Healthcare (MOH) Stock Undervalued Right Now?
Neutral Sentiment:
Molina shares fell alongside Centene’s 40% drop, with MOH down about 22% as industry players pull guidance over unexpected exchange market morbidity.
Why Centene Stock Dropped 40% — And Whether It's a Buy Now
Negative Sentiment:
Molina cut its Q2 2025 EPS guidance to $5.50 (versus $6.21 expected) and trimmed full-year EPS to $21.50–$22.50 versus $24.48 consensus.
Molina Healthcare (NYSE:MOH) Issues Q2 2025 Earnings Guidance
Molina Healthcare (NYSE:MOH) Releases FY 2025 Earnings Guidance
Negative Sentiment:
Medical cost inflation in Medicaid, Medicare and ACA plans drove Molina to slash profit targets, echoing warnings from Centene and UnitedHealth.
Health insurer Molina cuts profit targets as medical costs surge across industry
Negative Sentiment:
Preliminary Q2 results confirmed adjusted EPS of ~$5.50, and the annual profit forecast was lowered due to persistent medical cost pressures.
Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance
Negative Sentiment:
Bank of America reaffirmed a Sell rating on MOH and cut its price target to $248 amid the earnings miss and Medicaid funding uncertainty.
Sell Rating for Molina Healthcare Amid Earnings Miss and Medicaid Funding Uncertainty
Negative Sentiment:
MOH hit a new 52-week low as investors reassess the impact of rising costs and tighter guidance on future profitability.
Molina Healthcare (NYSE:MOH) Reaches New 12-Month Low - What's Next?
Posted 5h ago
AI Generated. May Contain Errors.